Utility of SARC-F in daycare facilities for older people.
SARC-F
community-dwelling older people
questionnaire
sarcopenia
screening tool
Journal
Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
18
07
2022
received:
02
05
2022
accepted:
26
07
2022
pubmed:
5
9
2022
medline:
7
10
2022
entrez:
4
9
2022
Statut:
ppublish
Résumé
SARC-F, a sarcopenia screening tool, has limited use but may be beneficial for detecting sarcopenia in frail older people. This study aimed to clarify the validity of the SARC-F questionnaire in older people. In this validation study, 74 (36 men; age, 81.9 ± 6.7 years, 38 women; age, 83 ± 6.2 years) community-dwelling older people who attended a daycare facility participated in our study. Participants completed the SARC-F and SARC-calf circumference (SARC-CalF) questionnaires, and their body composition, walk speed and grip strength were measured. Sarcopenia was determined using the Asian Working Group for Sarcopenia criteria, and the participants were divided into non-sarcopenia and sarcopenia groups. SARC-F and SARC-CalF scores were evaluated using receiver operating characteristic curve analysis for sarcopenia considering the area under the curve. Internal consistency was evaluated using Cronbach's alpha. The prevalence of sarcopenia, defined by physical characteristics, was 60.0% in men and 48.1% in women. The area under the curve of the SARC-F for sarcopenia was 0.703 (95% confidence interval [CI]: 0.585-0.821, P = 0.001). Cronbach's alpha was 0.81, and the internal consistency was high. SARC-F had lower sensitivity (0.47; 95% CI: 0.31-0.64) but higher specificity (0.78; 95% CI: 0.60-0.89) than the sensitivity and specificity of SARC-CalF, respectively, and the sensitivity of SARC-F was higher than that reported in previous studies. The SARC-F questionnaire is more sensitive in assessing sarcopenia in low-functioning populations and can be used as a screening tool for sarcopenia in long-term daycare facilities for older people rather than in community-based healthcare activities. Geriatr Gerontol Int 2022; 22: 889-893.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
889-893Subventions
Organisme : the Gunma foundation for medicine and health science
Informations de copyright
© 2022 Japan Geriatrics Society.
Références
Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16-31.
Chen LK, Woo J, Assantachai P et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21: 300-307.e2.
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013; 14: 531-532.
Tanaka S, Kamiya K, Hamazaki N et al. Utility of SARC-F for assessing physical function in elderly patients with cardiovascular disease. J Am Med Dir Assoc 2017; 18: 176-181.
Kurita N, Wakita T, Kamitani T, Wada O, Mizuno K. SARC-F validation and SARC-F + EBM derivation in musculoskeletal disease: the SPSS-OK study. J Nutr Health Aging 2019; 23: 732-738.
Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014; 15: 630-634.
Kera T, Kawai H, Hirano H et al. Limitations of SARC-F in the diagnosis of sarcopenia in community-dwelling older adults. Arch Gerontol Geriatr 2020; 87: 103959.
Wu TY, Liaw CK, Chen FC, Kuo KL, Chie WC, Yang RS. Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality. J Am Med Dir Assoc 2016; 17: 1129-1135.
Kera T, Kawai H, Hirano H et al. SARC-F: a validation study with community-dwelling older Japanese adults. Geriatr Gerontol Int 2019; 19: 1172-1178.
Ida S, Kaneko R, Murata K. SARC-F for screening of sarcopenia among older adults: a meta-analysis of screening test accuracy. J Am Med Dir Assoc 2018; 19: 685-689.
Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC. Grupo de Estudos em Composição corporal e Nutrição (COCONUT). Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 2016; 17: 1136-1141.
Bahat G, Oren MM, Yilmaz O, Kılıç C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to screen sarcopenia in community living older adults. J Nutr Health Aging 2018; 22: 1034-1038.
Lim WS, Chew J, Lim JP, Tay L, Hafizah N, Ding YY. Letter to the editor: case for validated instead of standard cut-offs for SARC-CalF. J Nutr Health Aging 2019; 23: 393-395.
Yang M, Lu J, Jiang J, Zeng Y, Tang H. Comparison of four sarcopenia screening tools in nursing home residents. Aging Clin Exp Res 2019; 31: 1481-1489.
Yang M, Hu X, Xie L et al. Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 2019; 20: 53-57.
Japan Ministry of Labour and Welfare. Long-Term Care Health Welf Serv Elderly 2016. [cited Mar 31 2022]. Available from: https://www.mhlw.go.jp/english/policy/care-welfare/care-welfare-elderly/index.html
Cao L, Chen S, Zou C et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 2014; 18: 277-283.
Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-930.
Willis BH. Spectrum bias-why clinicians need to be cautious when applying diagnostic test studies. Fam Pract 2008; 25: 390-396.